Skip to Content

SABCS: Some Older Women With Breast Cancer May Opt to Skip RT

MONDAY, Dec. 14, 2020 -- The omission of radiotherapy (RT) does not affect overall survival at 10 years after breast conserving surgery (BCS) for older women with hormone receptor-positive breast cancer, according to a study presented at the annual San Antonio Breast Cancer Symposium, held virtually from Dec. 8 to 11.

Ian H. Kunkler, from the University of Edinburgh in the United Kingdom, and colleagues examined the impact of locoregional RT after BCS on long-term outcomes in older patients receiving appropriate systemic therapy. A total of 1,326 patients aged ≥65 years, with axillary node-negative, hormone receptor- positive breast cancer were randomly assigned to either receive or not receive (658 and 668, respectively) whole breast RT; patients were followed for a median of 7.3 years.

The researchers found that at 10 years, ipsilateral breast tumor recurrence was 9.8 and 0.9 percent in the no RT and RT arms, respectively, with a hazard ratio of 0.12 (95 percent confidence interval, 0.05 to 0.31; P < 0.0001) for those receiving RT. Regional recurrence differed significantly (2.3 versus 0.5 percent with no RT and with RT, respectively; P = 0.014), but no differences were seen in contralateral breast cancer (P = 0.20) or distant metastases (P = 0.07). Breast cancer-free survival was 12.7 and 6.6 percent for the no RT and RT arms, respectively. At 10-years, overall survival was 80.4 and 81.0 percent without and with RT (P = 0.68).

"We believe that omission of radiation therapy after breast-conserving surgery should be an option for older patients," Kunkler said in a statement.

Press Release

More Information

© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

Financial Toxicity Linked to QOL After Breast Cancer Surgery

TUESDAY, Jan. 12, 2021 -- Financial toxicity (FT) is associated with worse quality of life (QOL) for breast cancer patients after mastectomy or lumpectomy, according to a study...

Statins May Protect Heart From Chemo for Early Breast Cancer

THURSDAY, Jan. 7, 2021 -- For women with early breast cancer treated with anthracyclines, statin exposure is associated with a lower risk for hospital presentation for heart...

New Mammogram-Based Measures Improve Breast Cancer Prediction

WEDNESDAY, Dec. 30, 2020 -- New mammogram-based risk measures based on brightness (Cirrocumulus) and texture (Cirrus) improve breast cancer risk prediction beyond an established...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.